Skip to main content
NCBI home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1986 Mar;13(1):69–75.

Verapamil-Potassium Cardioplegia: A Two-Year Experience with 470 Patients

George L Hicks Jr 1
PMCID: PMC324600  PMID: 15226834

Abstract

This prospective clinical study in cardiac surgery involves a 2-year experience with verapamil-potassium cardioplegia in 470 patients. Protective benefits, associated with calcium channel blockers during cellular ischemia, have increased their utilization in cardioplegic solutions during open-heart surgery.

Analysis of the group includes preoperative, intraoperative, and postoperative variables. Preoperative data encompasses age, previous myocardial infarctions, ejection fraction, cardiac index, and risk factors. Analysis of operative data includes the type of operation performed, anesthetic agents, amount of cardioplegia solution, total peripheral resistance, fluid requirements, cross-clamp time and arrhythmias during reperfusion.

In this study, verapamil proved to be a safe and effective additive to standard potassium cardioplegia. Beneficial hemodynamic actions with myocardial preservative and antiarrhythmic effects were demonstrated. Although the “perfect solution” to myocardial preservation remains unknown, because of favorable experimental data and successful clinical trials, the continued use of verapamil-potassium cardioplegia appears justified.

Full text

PDF
69

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barner H. B., Jellinek M., Standeven J. W., Menz L. J., Hahn J. W. Cold blood-diltiazem cardioplegia. Ann Thorac Surg. 1982 Jan;33(1):55–63. doi: 10.1016/s0003-4975(10)63199-2. [DOI] [PubMed] [Google Scholar]
  2. Boudoulas H., Snyder G. L., Lewis R. P., Kates R. E., Karayannacos P. E., Vasko J. S. Safety and rationale for continuation of propranolol therapy during coronary bypass operation. Ann Thorac Surg. 1978 Sep;26(3):222–227. doi: 10.1016/s0003-4975(10)63674-0. [DOI] [PubMed] [Google Scholar]
  3. Christlieb I. Y., Clark R. E., Sobel B. E. Three-hour preservation of the hypothermic globally ischemic heart with nifedipine. Surgery. 1981 Dec;90(6):947–955. [PubMed] [Google Scholar]
  4. Clark M. B., Dwyer E. M., Jr Electromechanical dissociation after intravenous verapamil. N Y State J Med. 1983 Oct-Nov;83(11-12):1181–1182. [PubMed] [Google Scholar]
  5. Clark R. E., Christlieb I. Y., Ferguson T. B., Weldon C. S., Marbarger J. P., Sobel B. E., Roberts R., Henry P. D., Ludbrook P. A., Biello D. Laboratory and initial clinical studies of nifedipine, a calcium antagonist for improved myocardial preservation. Ann Surg. 1981 Jun;193(6):719–732. doi: 10.1097/00000658-198106000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clark R. E., Christlieb I. Y., Spratt J. A., Henry P. D., Fischer A. E., Williamson J. R., Sobel B. E. Myocardial preservation with nifedipine: a comparative study at normothermia. Ann Thorac Surg. 1981 Jan;31(1):3–20. doi: 10.1016/s0003-4975(10)61310-0. [DOI] [PubMed] [Google Scholar]
  7. Clark R. E., Magovern G. J., Christlieb I. Y., Boe S. Nifedipine cardioplegia experience: results of a 3-year cooperative clinical study. Ann Thorac Surg. 1983 Dec;36(6):654–663. doi: 10.1016/s0003-4975(10)60274-3. [DOI] [PubMed] [Google Scholar]
  8. Ellis R. J., Mavroudis C., Gardner C., Turley K., Ullyot D., Ebert P. A. Relationship between atrioventricular arrhythmias and the concentration of K+ ion in cardioplegic solution. J Thorac Cardiovasc Surg. 1980 Oct;80(4):517–526. [PubMed] [Google Scholar]
  9. Engelman R. M., Rousou J. H., Vertrees R. A., Rohrer C., Auvil J. Safety of prolonged ischemic arrest using hypothermic cardioplegia. J Thorac Cardiovasc Surg. 1980 May;79(5):705–712. [PubMed] [Google Scholar]
  10. Henry P. D. Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. Am J Cardiol. 1980 Dec 1;46(6):1047–1058. doi: 10.1016/0002-9149(80)90366-5. [DOI] [PubMed] [Google Scholar]
  11. Hicks G. L., Jr, Salley R. K., DeWeese J. A. Calcium channel blockers: an intraoperative and postoperative trial in women. Ann Thorac Surg. 1984 Apr;37(4):319–323. doi: 10.1016/s0003-4975(10)60739-4. [DOI] [PubMed] [Google Scholar]
  12. Jardin F., Eveleigh M. C., Gurdjian F., Delille F., Margairaz A. Venous admixture in human septic shock: comparative effects of blood volume expansion, dopamine infusion and isoproterenol infusion on mismatching of ventilation and pulmonary blood flow in peritonitis. Circulation. 1979 Jul;60(1):155–159. doi: 10.1161/01.cir.60.1.155. [DOI] [PubMed] [Google Scholar]
  13. Johnson L. W., Dickstein R. A., Fruehan C. T., Kane P., Potts J. L., Smulyan H., Webb W. R., Eich R. H. Prophylactic digitalization for coronary artery bypass surgery. Circulation. 1976 May;53(5):819–822. doi: 10.1161/01.cir.53.5.819. [DOI] [PubMed] [Google Scholar]
  14. Kawai C., Konishi T., Matsuyama E., Okazaki H. Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies. Circulation. 1981 May;63(5):1035–1042. doi: 10.1161/01.cir.63.5.1035. [DOI] [PubMed] [Google Scholar]
  15. Lange R., Ingwall J., Hale S. L., Alker K. J., Braunwald E., Kloner R. A. Preservation of high-energy phosphates by verapamil in reperfused myocardium. Circulation. 1984 Oct;70(4):734–741. doi: 10.1161/01.cir.70.4.734. [DOI] [PubMed] [Google Scholar]
  16. Magovern G. J., Dixon C. M., Burkholder J. A. Improved myocardial protection with nifedipine and potassium-based cardioplegia. J Thorac Cardiovasc Surg. 1981 Aug;82(2):239–244. [PubMed] [Google Scholar]
  17. Mori H., Nagata M., Miyazaki T., Sakurai K., Ogawa S., Hattori S., Takahashi M., Nakamura Y. Protection of hypoxic myocardium by intracoronary administration of verapamil in open-chest dogs. Circulation. 1984 Oct;70(4):742–747. doi: 10.1161/01.cir.70.4.742. [DOI] [PubMed] [Google Scholar]
  18. Nayler W. G., Ferrari R., Williams A. Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. Am J Cardiol. 1980 Aug;46(2):242–248. doi: 10.1016/0002-9149(80)90064-8. [DOI] [PubMed] [Google Scholar]
  19. Nayler W. G., Grau A., Slade A. A protective effect of verapamil on hypoxic heart muscle. Cardiovasc Res. 1976 Nov;10(6):650–662. doi: 10.1093/cvr/10.6.650. [DOI] [PubMed] [Google Scholar]
  20. Parker F. B., Jr, Greiner-Hayes C., Bove E. L., Marvasti M. A., Johnson L. W., Eich R. H. Supraventricular arrhythmias following coronary artery bypass. The effect of preoperative digitalis. J Thorac Cardiovasc Surg. 1983 Oct;86(4):594–600. doi: 10.1016/0022-460x(83)91023-4. [DOI] [PubMed] [Google Scholar]
  21. Pinsky W. W., Lewis R. M., McMillin-Wood J. B., Hara H., Hartley C. J., Gillette P. C., Entman M. L. Myocardial protection from ischemic arrest: potassium and verapamil cardioplegia. Am J Physiol. 1981 Mar;240(3):H326–H335. doi: 10.1152/ajpheart.1981.240.3.H326. [DOI] [PubMed] [Google Scholar]
  22. Reimer K. A., Lowe J. E., Jennings R. B. Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs. Circulation. 1977 Apr;55(4):581–587. doi: 10.1161/01.cir.55.4.581. [DOI] [PubMed] [Google Scholar]
  23. Salerni R., Reddy P. S., Sherman M. E., O'Toole J. D., Leon D. F., Shaver J. A. Pressure and sound correlates of the mitral valve ecyocardiogram in mitral stenosis. Circulation. 1978 Jul;58(1):119–125. doi: 10.1161/01.cir.58.1.119. [DOI] [PubMed] [Google Scholar]
  24. Singh B. N., Ellrodt G., Peter C. T. Verapamil: a review of its pharmacological properties and therapeutic use. Drugs. 1978 Mar;15(3):169–197. doi: 10.2165/00003495-197815030-00001. [DOI] [PubMed] [Google Scholar]
  25. Tchervenkov C. I., Wynands J. E., Symes J. F., Malcolm I. D., Dobell A. R., Morin J. E. Electrical behavior of the heart following high-potassium cardioplegia. Ann Thorac Surg. 1983 Sep;36(3):314–319. doi: 10.1016/s0003-4975(10)60134-8. [DOI] [PubMed] [Google Scholar]
  26. Vouhé P. R., Hélias J., Grondin C. M. Myocardial protection through cold cardioplegia using diltiazem, a calcium channel blocker. Ann Thorac Surg. 1980 Oct;30(4):342–348. doi: 10.1016/s0003-4975(10)61272-6. [DOI] [PubMed] [Google Scholar]
  27. Weishaar R., Ashikawa K., Bing R. J. Effect of diltiazem, a calcium antagonist, on myocardial ischemia. Am J Cardiol. 1979 Jun;43(6):1137–1143. doi: 10.1016/0002-9149(79)90144-9. [DOI] [PubMed] [Google Scholar]
  28. Yamamoto F., Manning A. S., Braimbridge M. V., Hearse D. J. Cardioplegia and slow calcium-channel blockers. Studies with verapamil. J Thorac Cardiovasc Surg. 1983 Aug;86(2):252–261. [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES